561
|
|
|
FXYD domain containing ion transport regulator 2 |
ATP1G1, HOMG2 |
|
562
|
|
|
FXYD domain containing ion transport regulator 3 |
MAT8, PLML |
|
563
|
|
|
FXYD domain containing ion transport regulator 4 |
CHIF |
|
564
|
|
|
FXYD domain containing ion transport regulator 5 |
DYSAD, HSPC113, IWU1, KCT1, OIT2, PRO6241, RIC |
|
565
|
|
|
FXYD domain containing ion transport regulator 6 |
- |
|
566
|
|
|
FXYD6-FXYD2 readthrough |
FXYD6 |
|
567
|
|
|
FYN binding protein 1 |
ADAP, FYB, PRO0823, SLAP-130, SLAP130, THC3 |
Central nervous system cancer, Congenital small-platelet thrombocytopenia, Allergic contact dermatitis, Glioblastoma, Glioma, Major depressive disorder, Mood disorder, Nonalcoholic fatty liver disease, Thrombocytopenia, Diabetes mellitus type 2, Vascular dementia |
568
|
|
|
FYN binding protein 2 |
ARAP, C1orf168 |
|
569
|
|
|
FYVE and coiled-coil domain autophagy adaptor 1 |
CATC2, CTRCT18, RUFY3, ZFYVE7 |
|
570
|
|
|
FYN proto-oncogene, Src family tyrosine kinase |
SLK, SYN, p59-FYN |
Alzheimer disease, Androgenetic alopecia, Eczema, Autoimmune thyroid disease, Bipolar disorder, Catalepsy, Color vision deficiency, Hypothyroidism, Inflammatory skin disease, Insomnia, T-cell leukemia-lymphoma, Premature ovarian failure, Parkinson disease, Psoriasis, Psoriasis vulgaris, Pulmonary fibrosis, Schizophrenia, Stomach neoplasms, Diabetes mellitus type 1, Diabetes mellitus type 2View all (5 more) |